Listing of Pharmacological Classifications

A : Alimentary Tract and Metabolism

• A01: Stomatological preparations

  • A01A : Stomatological preparations

    • A01AA : Caries prophylactic agents

      • Sodium Fluoride

    • A01AB : Antiinfectives and antiseptics for local oral treatment

      • Chlorhexidine

      • Choline Salicylate + Cetylpyridinium

      • Minocycline

    • A01AC : Corticosteroids for local oral treatment

      • Chlorhexidine + Lidocaine + Triamcinolone

      • Dexamethasone

      • Lidocaine + Triamcinolone

      • Triamcinolone

    • A01AD : Other agents for local oral treatment

      • Aminacrine + Lidocaine

      • Benzalkonium + Choline Salicylate

      • Benzydamine

      • Benzydamine + Cetylpyridinium

      • Benzydamine + Chlorhexidine

      • Cetalkonium Chloride + Choline Salicylate

      • Cetylpyridinium + Lidocaine

      • Dichlorobenzyl Alcohol + Benzydamine + Lidocaine

• A02: Drugs for acid related disorders

  • A02A : Antacids

    • A02AA : Magnesium compounds

    • A02AB : Aluminium compounds

      • Aluminium Hydroxide

      • Aluminium Oxide

    • A02AC : Calcium compounds

    • A02AD : Combinations and complexes of aluminium, calcium and magnesium compounds

      • Aluminium Hydroxide + Magnesium Trisilicate

      • Calcium Carbonate + Magnesium Carbonate

    • A02AF : Antacids with antiflatulents

      • Aluminium Hydroxide + Dimethicone + Magnesium Hydroxide

      • Aluminium Hydroxide + Dimethicone + Magnesium Oxide

      • Aluminium Hydroxide + Magnesium Carbonate + Dicycloverine + Dimethicone

      • Aluminium Hydroxide + Magnesium Carbonate + Dicycloverine + Simethicone

      • Aluminium Hydroxide + Magnesium Hydroxide + Simethicone

      • Aluminium Hydroxide + Magnesium Trisilicate + Simethicone

      • Citric Acid + Simethicone + Sodium Bicarbonate

    • A02AG : Antacids with antispasmodics

      • Aluminium Hydroxide + Magnesium Carbonate + Dicycloverine + Dimethicone

    • A02AH : Antacids with sodium bicarbonate

      • Aluminium Hydroxide + Magnesium Carbonate + Sodium Bicarbonate

      • Aluminium Hydroxide + Magnesium Trisilicate + Sodium Bicarbonate + Liquorice Extract

      • Calcium Carbonate + Sodium Bicarbonate

      • Magnesium Carbonate + Magnesium Trisilicate + Sodium Bicarbonate

      • Magnesium Carbonate + Sodium Bicarbonate

      • Sodium Bicarbonate

    • A02AX : Antacids, other combinations

  • A02B : Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

    • A02BA : H2-receptor antagonists

      • Cimetidine

      • Famotidine

      • Ranitidine

    • A02BB : Prostaglandins

      • Misoprostol

    • A02BC : Proton pump inhibitors

      • Dexlansoprazole

      • Esomeprazole

      • Omeprazole

      • Pantoprazole

      • Rabeprazole

      • Tegoprazan

      • Vonoprazan

    • A02BD : Combinations for eradication of Helicobacter pylori

    • A02BX : Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

      • Aluminium Hydroxide + Biodiastase + Methylmethionine Sulfonium Chloride

      • Potassium Bicarbonate + Sodium Alginate

      • Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate

      • Sucralfate

  • A02X : Other drugs for acid related disorders

• A03: Drugs for functional gastrointestinal disorders

  • A03A : Drugs for functional gastrointestinal disorders

    • A03AA : Synthetic anticholinergics, esters with tertiary amino group

      • Mebeverine

      • Trimebutine

    • A03AB : Synthetic anticholinergics, quaternary ammonium compounds

    • A03AC : Synthetic antispasmodics, amides with tertiary amines

    • A03AD : Papaverine and derivatives

    • A03AE : Serotonin receptor antagonists

    • A03AX : Other drugs for functional gastrointestinal disorders

      • Alverine + Simethicone

      • Dicycloverine + Simethicone

      • Dimethicone

      • Peppermint Oil

      • Simethicone

  • A03B : Belladonna and derivatives, plain

    • A03BA : Belladonna alkaloids, tertiary amines

      • Atropine

    • A03BB : Belladonna alkaloids, semisynthetic, quaternary ammonium compounds

      • Hyoscine Butylbromide

  • A03C : Antispasmodics in combination with psycholeptics

    • A03CA : Synthetic anticholinergic agents in combination with psycholeptics

      • Clidinium + Chlordiazepoxide

    • A03CB : Belladonna and derivatives in combination with psycholeptics

    • A03CC : Other antispasmodics in combination with psycholeptics

  • A03D : Antispasmodics in combination with analgesics

    • A03DA : Synthetic anticholinergic agents in combination with analgesics

    • A03DB : Belladonna and derivatives in combination with analgesics

    • A03DC : Other antispasmodics in combination with analgesics

  • A03E : Antispasmodics and anticholinergics in combination with other drugs

    • A03EA : Antispasmodics, psycholeptics and analgesics in combination

    • A03ED : Antispasmodics in combination with other drugs

      • Dicycloverine + Simethicone

  • A03F : Propulsives

    • A03FA : Propulsives

      • Domperidone

      • Metoclopramide

• A04: Antiemetics and antinauseants

  • A04A : Antiemetics and antinauseants

    • A04AA : Serotonin (5HT3) antagonists

      • Fosnetupitant + Palonosetron

      • Granisetron

      • Netupitant + Palonosetron

      • Ondansetron

      • Palonosetron

    • A04AD : Other antiemetics

      • Aprepitant

      • Fosaprepitant

• A05: Bile and liver therapy

  • A05A : Bile therapy

    • A05AA : Bile acids and derivatives

      • Ursodeoxycholic Acid

    • A05AB : Preparations for biliary tract therapy

    • A05AX : Other drugs for bile therapy

  • A05B : Liver therapy, lipotropics

    • A05BA : Liver therapy

      • L-Ornithine-L-Aspartate

  • A05C : Drugs for bile therapy and lipotropics in combination

• A06: Drugs for constipation

  • A06A : Drugs for constipation

    • A06AA : Softeners, emollients

      • Liquid Paraffin

      • Magnesium Sulfate + Glycerin

    • A06AB : Contact laxatives

      • Aloe + Rhubarb + Senna

      • Bisacodyl

      • Citric Acid + Magnesium Oxide + Sodium Picosulfate

      • Sennosides

    • A06AC : Bulk-forming laxatives

    • A06AD : Osmotically acting laxatives

      • Compound Polyethylene Glycol

      • Dibasic Sodium Phosphate + Monobasic Sodium Phosphate

      • Lactulose

      • Macrogol

    • A06AG : Enemas

      • Dibasic Sodium Phosphate + Monobasic Sodium Phosphate

      • Glycerin + Sodium Chloride

      • Glycerin + Sodium Citrate + Sorbitol

      • Sodium Chloride

    • A06AH : Peripheral opioid receptor antagonists

      • Methylnaltrexone

    • A06AX : Other drugs for constipation

      • Elobixibat

      • Glycerol

      • Prucalopride

• A07: Antidiarrheals, intestinal antiinflammatory/antiinfective agents

  • A07A : Intestinal antiinfectives

    • A07AA : Antibiotics

      • Neomycin + Nystatin + Polymyxin B

      • Nystatin

      • Rifaximin

      • Vancomycin

    • A07AB : Sulfonamides

    • A07AC : Imidazole derivatives

    • A07AX : Other intestinal antiinfectives

      • Nifuroxazide

  • A07B : Intestinal adsorbents

    • A07BA : Charcoal preparations

      • Charcoal (activated)

    • A07BB : Bismuth preparations

    • A07BC : Other intestinal adsorbents

      • Diosmectite

      • Kaolin

      • Kaolin + Magnesium Carbonate + Sodium Bicarbonate

      • Kaolin Colloidal

  • A07C : Electrolytes with carbohydrates

    • A07CA : Oral rehydration salt formulations

  • A07D : Antipropulsives

    • A07DA : Antipropulsives

      • Atropine + Diphenoxylate

      • Loperamide

  • A07E : Intestinal antiinflammatory agents

    • A07EA : Corticosteroids acting locally

      • Budesonide

    • A07EB : Antiallergic agents, excl. corticosteroids

    • A07EC : Aminosalicylic acid and similar agents

      • Mesalazine

      • Sulfasalazine

  • A07F : Antidiarrheal microorganisms

    • A07FA : Antidiarrheal microorganisms

      • Probiotics

      • Saccharomyces boulardii

  • A07X : Other antidiarrheals

    • A07XA : Other antidiarrheals

      • Racecadotril

• A08: Antiobesity preparations, excl. diet products

  • A08A : Antiobesity preparations, excl. diet products

    • A08AA : Centrally acting antiobesity products

      • Bupropion + Naltrexone

      • Phentermine

    • A08AB : Peripherally acting antiobesity products

      • Orlistat

    • A08AX : Other antiobesity drugs

• A09: Digestives, incl. enzymes

  • A09A : Digestives, incl. enzymes

    • A09AA : Enzyme preparations

      • Digestive Enzymes

    • A09AB : Acid preparations

    • A09AC : Enzyme and acid preparations, combinations

• A10: Drugs used in diabetes

  • A10A : Insulins and analogues

    • A10AB : Insulins and analogues for injection, fast-acting

      • Insulin Aspart [Fiasp]

      • Insulin Aspart [Kirsty™]

      • Insulin Aspart [Novorapid]

      • Insulin Glulisine [Apidra]

      • Insulin Lispro [Humalog]

      • Insulin Soluble (Human) [Actrapid]

    • A10AC : Insulins and analogues for injection, intermediate-acting

      • Insulin Isophane (Human) [Insulatard]

    • A10AD : Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting

      • Insulin Aspart + Insulin Aspart Protamine [Novomix]

      • Insulin Aspart + Insulin Degludec [Ryzodeg®]

      • Insulin Lispro + Insulin Lispro Protamine [Humalog Mix]

      • Insulin Soluble (Human) + Insulin Isophane (Human) [Mixtard]

    • A10AE : Insulins and analogues for injection, long-acting

      • Insulin Degludec [Tresiba®]

      • Insulin Detemir [Levemir®]

      • Insulin Glargine [Lantus]

      • Insulin Glargine [Semglee™]

      • Insulin Glargine [Toujeo]

      • Insulin Glargine + Lixisenatide [Soliqua]

    • A10AF : Insulins and analogues for inhalation

  • A10B : Blood glucose lowering drugs, excl. insulins

    • A10BA : Biguanides

      • Metformin

    • A10BB : Sulfonylureas

      • Glibenclamide

      • Gliclazide

      • Glimepiride

      • Glipizide

      • Tolbutamide

    • A10BC : Sulfonamides (heterocylic)

    • A10BD : Combinations of oral blood glucose lowering drugs

      • Dapagliflozin + Metformin

      • Dapagliflozin + Sitagliptin

      • Empagliflozin + Linagliptin

      • Empagliflozin + Metformin

      • Glibenclamide + Metformin

      • Linagliptin + Metformin

      • Metformin + Sitagliptin

      • Metformin + Vildagliptin

    • A10BF : Alpha glucosidase inhibitors

      • Acarbose

    • A10BG : Thiazolidinediones

      • Pioglitazone

    • A10BH : Dipeptidyl peptidase 4 (DPP-4) inhibitors

      • Linagliptin

      • Sitagliptin

      • Vildagliptin

    • A10BJ : Glucagon-like peptide-1 (GLP-1) analogues

      • Dulaglutide [Trulicity]

      • Liraglutide

      • Semaglutide

    • A10BK : Sodium-glucose co-transporter 2 (SGLT2) inhibitors

      • Canagliflozin

      • Dapagliflozin

      • Empagliflozin

    • A10BX : Other blood glucose lowering drugs, excl. insulins

      • Repaglinide

      • Tirzepatide

  • A10X : Other drugs used in diabetes

    • A10XA : Aldose reductase inhibitors

    • A10XX : Other drugs used in diabetes

• A11: Vitamins

  • A11A : Multivitamins, combinations

    • A11AA : Multivitamins with minerals

    • A11AB : Multivitamins, other combinations

  • A11B : Multivitamins, plain

    • A11BA : Multivitamins, plain

  • A11C : Vitamin A and D, incl. combination of the two

    • A11CA : Vitamin A, plain

    • A11CB : Vitamin A and D in combination

    • A11CC : Vitamin D and analogues

      • Alfacalcidol

      • Calcitriol

      • Vitamin D3 (Colecalciferol)

  • A11D : Vitamin B1, plain and in combination with vitamin B6 and B12

    • A11DA : Vitamin B1, plain

      • Sulbutiamine

    • A11DB : Vitamin B1 in combination with vitamin B6 and/or vitamin B12

      • Vitamin B1 + Vitamin B6 + Vitamin B12

  • A11E : Vitamin B-complex, incl. combinations

    • A11EA : Vitamin B-complex, plain

    • A11EB : Vitamin B-complex with vitamin C

    • A11EC : Vitamin B-complex with minerals

    • A11ED : Vitamin B-complex with anabolic steroids

    • A11EX : Vitamin B-complex, other combinations

  • A11G : Ascorbic acid (vitamin C), incl. combinations

    • A11GA : Ascorbic acid (vitamin C), plain

      • Vitamin C (Ascorbic Acid)

    • A11GB : Ascorbic acid (vitamin C), combinations

  • A11H : Other plain vitamin preparations

    • A11HA : Other plain vitamin preparations

  • A11J : Other vitamin products, combinations

    • A11JA : Combinations of vitamins

      • Vitamin B1 + Vitamin B6 + Vitamin B12 + Vitamin E

    • A11JB : Vitamins with minerals

    • A11JC : Vitamins, other combinations

• A12: Mineral supplements

  • A12A : Calcium

    • A12AA : Calcium

    • A12AX : Calcium, combinations with vitamin D and/or other drugs

  • A12B : Potassium

    • A12BA : Potassium

      • Citric Acid Monohydrate + Potassium Citrate

      • Potassium Chloride

      • Potassium Citrate

  • A12C : Other mineral supplements

    • A12CA : Sodium

      • Dextrose + Sodium Chloride

    • A12CB : Zinc

      • Zinc

    • A12CC : Magnesium

      • Magnesium Sulfate

    • A12CD : Fluoride

    • A12CE : Selenium

    • A12CX : Other mineral products

• A13: Tonics

  • A13A : Tonics

• A14: Anabolic agents for systemic use

  • A14A : Anabolic steroids

    • A14AA : Androstan derivatives

      • Oxymetholone

    • A14AB : Estren derivatives

      • Nandrolone Decanoate

  • A14B : Other anabolic agents

• A15: Appetite stimulants

• A16: Other alimentary tract and metabolism products

  • A16A : Other alimentary tract and metabolism products

    • A16AA : Amino acids and derivatives

    • A16AB : Enzymes

      • Agalsidase Alfa [Replagal]

      • Agalsidase Beta [Fabrazyme®]

      • Alglucosidase Alfa [Myozyme®]

      • Asfotase Alfa [Strensiq]

      • Avalglucosidase Alfa [Nexviazyme]

      • Galsulfase [Naglazyme]

      • Idursulfase [Elaprase™]

      • Imiglucerase [Cerezyme®]

      • Laronidase

      • Pegunigalsidase Alfa [Elfabrio]

      • Taliglucerase Alfa [Elelyso]

      • Velaglucerase Alfa [Vpriv]

    • A16AX : Various alimentary tract and metabolism products

B : Blood and blood forming organs

• B01: Antithrombotic agents

  • B01A : Antithrombotic agents

    • B01AA : Vitamin K antagonists

      • Warfarin

    • B01AB : Heparin group

      • Bemiparin

      • Dalteparin

      • Enoxaparin

      • Heparin

      • Heparinised Saline

      • Nadroparin

    • B01AC : Platelet aggregation inhibitors excl. heparin

      • Aspirin

      • Aspirin + Clopidogrel

      • Clopidogrel

      • Dipyridamole

      • Epoprostenol

      • Iloprost

      • Selexipag

      • Ticagrelor

      • Ticlopidine

      • Tirofiban

    • B01AD : Enzymes

      • Alteplase [Actilyse]

      • Tenecteplase [Metalyse]

      • Urokinase [Urokinase-Green Cross]

    • B01AE : Direct thrombin inhibitors

      • Dabigatran Etexilate

    • B01AF : Direct factor Xa inhibitors

      • Apixaban

      • Edoxaban

      • Rivaroxaban

    • B01AX : Other antithrombotic agents

      • Fondaparinux

• B02: Antihemorrhagics

  • B02A : Antifibrinolytics

    • B02AA : Amino acids

      • Tranexamic Acid

    • B02AB : Proteinase inhibitors

      • Aprotinin [Trasylol]

  • B02B : Vitamin K and other hemostatics

    • B02BA : Vitamin K

    • B02BB : Fibrinogen

      • Fibrinogen, Human [Fibryga]

      • Fibrinogen, Human [Haemocomplettan P]

    • B02BC : Local hemostatics

      • Aprotinin + Calcium Chloride + Fibrinogen, Human + Thrombin [Artiss]

      • Aprotinin + Calcium Chloride + Fibrinogen, Human + Thrombin [Tisseel]

      • Aprotinin + Calcium Chloride Dihydrate + Human Plasma Coagulation Factor XIII (pd-FXIII) + Fibrinogen, Human + Thrombin [Beriplast]

      • Fibrinogen, Human + Thrombin [TachoSil]

      • Fibrinogen, Human + Thrombin [VeraSeal]

    • B02BD : Blood coagulation factors

      • Coagulation Factor II, IX, VII and X + Protein C + Protein S [Octaplex]

      • Coagulation Factor IX (Human) [AlphaNine SD]

      • Coagulation Factor IX (Human) [Profilnine]

      • Coagulation Factor IX (Human) [Replenine-VF]

      • Extended Half-life Recombinant Factor VIII (Rurioctocog Alfa Pegol) [Adynovate]

      • Factor Eight Inhibitor Bypassing Activity [FEIBA]

      • Plasma-Derived Factor VIII [Beriate]

      • Plasma-Derived Factor VIII [Fanhdi]

      • Plasma-Derived Factor VIII [Haemoctin SDH 1000]

      • Plasma-Derived Factor VIII [Haemoctin SDH 250]

      • Plasma-Derived Factor VIII [Haemoctin SDH 500]

      • Plasma-Derived Factor VIII [Koāte-DVI]

      • Plasma-Derived Factor VIII [Octanate]

      • Plasma-Derived Factor VIII + Von Willebrand Factor [Alphanate]

      • Plasma-Derived Factor VIII + Von Willebrand Factor [Optivate]

      • Recombinant Factor IX [BeneFIX]

      • Recombinant Factor IX [Idelvion]

      • Recombinant Factor VIIa [NovoSeven®]

      • Recombinant Factor VIII [Advate]

      • Recombinant Factor VIII [Afstyla]

      • Recombinant Factor VIII [NovoEight]

      • Recombinant Factor VIII [Nuwiq]

      • Recombinant Factor VIII [Xyntha]

    • B02BX : Other systemic hemostatics

      • Eltrombopag

      • Emicizumab [Hemlibra]

      • Etamsylate

      • Marstacimab [Hympavzi]

      • Romiplostim [Romiplate]

• B03: Antianemic preparations

  • B03A : Iron preparations

    • B03AA : Iron bivalent, oral preparations

      • Ferrous Sodium Citrate

    • B03AB : Iron trivalent, oral preparations

      • Iron Polymaltose

    • B03AC : Iron, parenteral preparations

      • Ferric Carboxymaltose

      • Ferric Derisomaltose

      • Iron Sucrose

    • B03AD : Iron in combination with folic acid

      • Iron Polymaltose + Vitamin B9

    • B03AE : Iron in other combinations

      • Ferrous Sulphate + Multivitamins

  • B03B : Vitamin B12 and folic acid

    • B03BA : Vitamin B12 (cyanocobalamin and analogues)

      • Vitamin B12 (Cyanocobalamin)

      • Vitamin B12 (Mecobalamin)

    • B03BB : Folic acid and derivatives

  • B03X : Other antianemic preparations

    • B03XA : Other antianemic preparations

      • Darbepoetin Alfa [NESP]

      • Epoetin Alfa [Eprex]

      • Epoetin Beta [Recormon]

      • Luspatercept [Reblozyl]

      • Methoxy Polyethylene Glycol-Epoetin Beta [Mircera]

• B05: Blood substitutes and perfusion solutions

  • B05A : Blood and related products

    • B05AA : Blood substitutes and plasma protein fractions

      • Albumin [Albumin SG]

      • Albumin [Albunorm]

      • Albumin [Alburx]

      • Albumin [Albutein]

      • Albumin [Human Albumin Behring]

      • Albumin [Human Albumin Grifols]

      • Albumin [Plasbumin-25]

      • Albumin [Uman]

      • Albumin [Zenalb]

      • Gelatin Succinylated + Electrolytes

      • Gelatin Succinylated + Sodium Chloride

      • Hydroxyethylstarch + Sodium Chloride

      • Plasma Proteins (Human) [Plasmanate]

    • B05AX : Other blood products

  • B05B : I.V. solutions

    • B05BA : Solutions for parenteral nutrition

      • Amino Acids

      • Amino Acids + Dextrose + Electrolytes + Lipids

      • Amino Acids + Dextrose + Lipids

      • Dextrose

      • Medium-Chain Triglycerides + Fish Oil + Olive Oil + Soyabean Oil

      • Medium-Chain Triglycerides + Omega-3-Triglycerides + Soyabean Oil

      • Soyabean Oil + Medium-Chain Triglycerides

    • B05BB : Solutions affecting the electrolyte balance

      • Compound Sodium Lactate

      • Dextrose + Potassium Chloride

      • Dextrose + Potassium Chloride + Sodium Chloride

      • Dextrose + Sodium Chloride

      • Electrolytes

      • Electrolytes + Malic Acid

      • Potassium Chloride

      • Potassium Chloride + Sodium Chloride

    • B05BC : Solutions producing osmotic diuresis

      • Mannitol

      • Mannitol + Sorbitol

  • B05C : Irrigating solutions

    • B05CA : Antiinfectives

    • B05CB : Salt solutions

      • Sodium Chloride

    • B05CX : Other irrigating solutions

  • B05D : Peritoneal dialytics

    • B05DA : Isotonic solutions

      • Intraperitoneal Dialysis

    • B05DB : Hypertonic solutions

      • Intraperitoneal Dialysis

  • B05X : I.V. solution additives

    • B05XA : Electrolye solutions

      • Calcium Gluconate

      • Magnesium Sulfate

      • Potassium Acetate

      • Potassium Chloride

      • Potassium Phosphate Monobasic

      • Selenium

      • Sodium Bicarbonate

      • Sodium Chloride

      • Sodium Glycerophosphate

      • Trace Elements

    • B05XB : Amino acids

      • Alanyl Glutamine

    • B05XC : Vitamins

      • Multivitamin for Parenteral

    • B05XX : Other i.v. solution additives

  • B05Z : Hemodialytics and hemofiltrates

    • B05ZA : Hemodialytics, concentrates

      • Haemodialysis Concentrate (For Bicarbonate Dialysis)

      • Sodium Bicarbonate for Haemodialysis

    • B05ZB : Hemofiltrates

      • Continuous Renal Replacement Therapy Solution

      • Hemofiltrates

      • Sodium Chloride + Sodium Citrate

• B06: Other hematological agents

  • B06A : Other hematological agents

    • B06AA : Enzymes

      • Hyaluronidase

    • B06AB : Heme products

    • B06AC : Drugs used in hereditary angioedema

    • B06AX : Other hematological agents

C : Cardiovascular system

• C01: Cardiac therapy

  • C01A : Cardiac glycosides

    • C01AA : Digitalis glycosides

      • Digoxin

    • C01AB : Scilla glycosides

    • C01AC : Strophanthus glycosides

    • C01AX : Other cardiac glycosides

  • C01B : Antiarrhythmics, class I and III

    • C01BA : Antiarrhythmics, class Ia

    • C01BB : Antiarrhythmics, class Ib

      • Lidocaine

    • C01BC : Antiarrhythmics, class Ic

      • Flecainide

      • Propafenone

    • C01BD : Antiarrhythmics, class III

      • Amiodarone

      • Dronedarone

    • C01BG : Other antiarrhythmics, class I and III

  • C01C : Cardiac stimulants excl. cardiac glycosides

    • C01CA : Adrenergic and dopaminergic agents

      • Adrenaline

      • Dobutamine

      • Dopamine

      • Ephedrine Hydrochloride

      • Ephedrine Sulfate

      • Norepinephrine

      • Phenylephrine

    • C01CE : Phosphodiesterase inhibitors

      • Milrinone

    • C01CX : Other cardiac stimulants

  • C01D : Vasodilators used in cardiac diseases

    • C01DA : Organic nitrates

      • Glyceryl Trinitrate

      • Isosorbide Dinitrate

      • Isosorbide Mononitrate

    • C01DB : Quinolone vasodilators

    • C01DX : Other vasodilators used in cardiac diseases

      • Vericiguat

  • C01E : Other cardiac preparations

    • C01EA : Prostaglandins

      • Alprostadil

    • C01EB : Other cardiac preparations

      • Adenosine

      • Ivabradine

      • Mavacamten

      • Ranolazine

      • Trimetazidine

    • C01EX : Other cardiac combination products

• C02: Antihypertensives

  • C02A : Antiadrenergic agents, centrally acting

    • C02AA : Rauwolfia alkaloids

    • C02AB : Methyldopa

      • Methyldopa

    • C02AC : Imidazoline receptor agonists

  • C02B : Antiadrenergic agents, ganglion-blocking

    • C02BA : Sulfonium derivatives

    • C02BB : Secondary and tertiary amines

    • C02BC : Bisquaternary ammonium compounds

  • C02C : Antiadrenergic agents, peripherally acting

    • C02CA : Alpha-adrenoreceptor antagonists

      • Doxazosin

      • Prazosin

    • C02CC : Guanidine derivatives

  • C02D : Arteriolar smooth muscle, agents acting on

    • C02DA : Thiazide derivatives

    • C02DB : Hydrazinophthalazine derivatives

      • Hydralazine

    • C02DC : Pyrimidine derivatives

    • C02DD : Nitroferricyanide derivatives

    • C02DG : Guanidine derivatives

  • C02K : Other antihypertensives

    • C02KA : Alkaloids, excl. rauwolfia

    • C02KB : Tyrosine hydroxylase inhibitors

    • C02KC : MAO inhibitors

    • C02KD : Serotonin antagonists

    • C02KN : Other antihypertensives

    • C02KX : Antihypertensives for pulmonary arterial hypertension

      • Ambrisentan

      • Bosentan

      • Macitentan

      • Macitentan + Tadalafil

      • Riociguat

      • Sotatercept [Winrevair®]

  • C02L : Antihypertensives and diuretics in combination

    • C02LA : Rauwolfia alkaloids and diuretics in combination

    • C02LB : Methyldopa and diuretics in combination

    • C02LC : Imidazoline receptor agonists in combination with diuretics

    • C02LE : Alpha-adrenoreceptor antagonists and diuretics

    • C02LF : Guanidine derivatives and diuretics

    • C02LG : Hydrazinophthalazine derivatives and diuretics

    • C02LK : Alkaloids, excl. rauwolfia, in combination with diuretics

    • C02LL : MAO inhibitors and diuretics

    • C02LN : Serotonin antagonists and diuretics

    • C02LX : Other antihypertensives and diuretics

  • C02N : Combinations of antihypertensives in ATC-gr. C02

• C03: Diuretics

  • C03A : Low-ceiling diuretics, thiazides

    • C03AA : Thiazides, plain

      • Hydrochlorothiazide

    • C03AB : Thiazides and potassium in combination

    • C03AH : Thiazides, combinations with psycholeptics and/or analgesics

    • C03AX : Thiazides, combinations with other drugs

  • C03B : Low-ceiling diuretics, excl. thiazides

    • C03BA : Sulfonamides, plain

      • Indapamide

    • C03BB : Sulfonamides and potassium in combination

    • C03BC : Mercurial diuretics

    • C03BD : Xanthine derivatives

    • C03BK : Sulfonamides, combinations with other drugs

    • C03BX : Other low-ceiling diuretics

  • C03C : High-ceiling diuretics

    • C03CA : Sulfonamides, plain

      • Bumetanide

      • Furosemide

    • C03CB : Sulfonamides and potassium in combination

    • C03CC : Aryloxyacetic acid derivatives

    • C03CD : Pyrazolone derivatives

    • C03CX : Other high-ceiling diuretics

  • C03D : Aldosterone antagonists and other potassium-sparing agents

    • C03DA : Aldosterone antagonists

      • Eplerenone

      • Finerenone

      • Spironolactone

    • C03DB : Other potassium-sparing agents

  • C03E : Diuretics and potassium-sparing agents in combination

    • C03EA : Low-ceiling diuretics and potassium-sparing agents

      • Amiloride + Hydrochlorothiazide

      • Triamterene + Hydrochlorothiazide

    • C03EB : High-ceiling diuretics and potassium-sparing agents

  • C03X : Other diuretics

    • C03XA : Vasopressin antagonists

      • Tolvaptan

• C04: Peripheral vasodilators

  • C04A : Peripheral vasodilators

    • C04AA : 2-amino-1-phenylethanol derivatives

    • C04AB : Imidazoline derivatives

    • C04AC : Nicotinic acid and derivatives

    • C04AD : Purine derivatives

      • Pentoxifylline

    • C04AE : Ergot alkaloids

    • C04AF : Enzymes

    • C04AX : Other peripheral vasodilators

• C05: Vasoprotectives

  • C05A : Agents for treatment of hemorrhoids and anal fissures for topical use

    • C05AA : Corticosteroids

      • Aesculin + Cinchocaine + Framycetin + Hydrocortisone

    • C05AB : Antibiotics

    • C05AD : Local anesthetics

      • Procaine

    • C05AE : Muscle relaxants

      • Glyceryl Trinitrate

    • C05AX : Other agents for treatment of hemorrhoids and anal fissures for topical use

  • C05B : Antivaricose therapy

    • C05BA : Heparins or heparinoids for topical use

      • Mucopolysaccharide Polysulphate

    • C05BB : Sclerosing agents for local injection

      • Phenol (in Almond Oil)

      • Polidocanol

    • C05BX : Other sclerosing agents

  • C05C : Capillary stabilizing agents

    • C05CA : Bioflavonoids

      • Diosmin + Hesperidin

    • C05CX : Other capillary stabilizing agents

  • C05X : Other Vasoprotectives

    • C05XX : Other Vasoprotectives

• C07: Beta blocking agents

  • C07A : Beta blocking agents

    • C07AA : Beta blocking agents, non-selective

      • Propranolol

      • Sotalol

    • C07AB : Beta blocking agents, selective

      • Acebutolol

      • Atenolol

      • Betaxolol

      • Bisoprolol

      • Metoprolol

      • Nebivolol

    • C07AG : Alpha and beta blocking agents

      • Carvedilol

      • Labetalol

  • C07B : Beta blocking agents and thiazides

    • C07BA : Beta blocking agents, non-selective, and thiazides

    • C07BB : Beta blocking agents, selective, and thiazides

    • C07BG : Alpha and beta blocking agents and thiazides

  • C07C : Beta blocking agents and other diuretics

    • C07CA : Beta blocking agents, non-selective, and other diuretics

    • C07CB : Beta blocking agents, selective, and other diuretics

    • C07CG : Alpha and beta blocking agents and other diuretics

  • C07D : Beta blocking agents, thiazides and other diuretics

    • C07DA : Beta blocking agents, non-selective, thiazides and other diuretics

    • C07DB : Beta blocking agents, selective, thiazides and other diuretics

  • C07E : Beta blocking agents and vasodilators

    • C07EA : Beta blocking agents, non-selective, and vasodilators

    • C07EB : Beta blocking agents, selective, and vasodilators

  • C07F : Beta blocking agents, other combinations

    • C07FB : Beta blocking agents and calcium channel blockers

      • Amlodipine + Bisoprolol

      • Atenolol + Nifedipine

    • C07FX : Beta blocking agents, other combinations

• C08: Calcium channel blockers

  • C08C : Selective calcium channel blockers with mainly vascular effects

    • C08CA : Dihydropyridine derivatives

      • Amlodipine

      • Felodipine

      • Lacidipine

      • Levamlodipine

      • Nifedipine

      • Nimodipine

    • CO8CX : Other selective calcium channel blockers with mainly vascular effects

  • C08D : Selective calcium channel blockers with direct cardiac effects

    • C08DA : Phenylalkylamine derivatives

      • Verapamil

    • C08DB : Benzothiazepine derivatives

      • Diltiazem

  • C08E : Non-selective calcium channel blockers

    • C08EA : Phenylalkylamine derivatives

    • C08EX : Other non-selective calcium channel blockers

  • C08G : Calcium channel blockers and diuretics

    • C08GA : Calcium channel blockers and diuretics

      • Amlodipine + Indapamide

• C09: Agents acting on the renin-angiotensin system

  • C09A : ACE inhibitors, plain

    • C09AA : ACE inhibitors, plain

      • Captopril

      • Enalapril

      • Imidapril

      • Lisinopril

      • Perindopril Arginine

      • Perindopril Erbumine

      • Ramipril

  • C09B : ACE inhibitors, combinations

    • C09BA : ACE inhibitors and diuretics

      • Enalapril + Hydrochlorothiazide

      • Indapamide + Perindopril Arginine

    • C09BB : ACE inhibitors and calcium channel blockers

      • Amlodipine + Perindopril Arginine

      • Amlodipine + Perindopril Erbumine

    • C09BX : ACE inhibitors, other combinations

      • Amlodipine + Indapamide + Perindopril Arginine

      • Bisoprolol + Perindopril Arginine

  • C09C : Angiotensin II receptor blockers (ARBs), plain

    • C09CA : Angiotensin II receptor blockers (ARBs), plain

      • Candesartan Cilexetil

      • Eprosartan

      • Fimasartan

      • Irbesartan

      • Losartan

      • Olmesartan Medoxomil

      • Telmisartan

      • Valsartan

  • C09D : Angiotensin II Receptor Blockers (ARBs), combinations

    • C09DA : Angiotensin II receptor blockers (ARBs) and diuretics

      • Candesartan Cilexetil + Hydrochlorothiazide

      • Hydrochlorothiazide + Irbesartan

      • Hydrochlorothiazide + Telmisartan

      • Hydrochlorothiazide + Valsartan

      • Losartan + Hydrochlorothiazide

    • C09DB : Angiotensin II receptor blockers (ARBs) and calcium channel blockers

      • Amlodipine + Irbesartan

      • Amlodipine + Losartan

      • Amlodipine + Olmesartan Medoxomil

      • Amlodipine + Telmisartan

      • Amlodipine + Valsartan

    • C09DX : Angiotensin II receptor blockers (ARBs), other combinations

      • Amlodipine + Hydrochlorothiazide + Valsartan

      • Sacubitril + Valsartan

  • C09X : Other agents acting on the renin-angiotensin system

    • C09XA : Renin-inhibitors

    • C09XX : Other agents acting on the renin-angiotensin system

• C10: Lipid modifying agents

  • C10A : Lipid modifying agents, plain

    • C10AA : HMG CoA reductase inhibitors

      • Atorvastatin

      • Lovastatin

      • Pitavastatin

      • Pravastatin

      • Rosuvastatin

      • Simvastatin

    • C10AB : Fibrates

      • Bezafibrate

      • Choline Fenofibrate

      • Fenofibrate

      • Gemfibrozil

      • Pemafibrate

    • C10AC : Bile acid sequestrants

      • Colestyramine

    • C10AD : Nicotinic acid and derivatives

    • C10AX : Other lipid modifying agents

      • Alirocumab [Praluent]

      • Evolocumab [Repatha]

      • Ezetimibe

      • Inclisiran

      • Omega-3-Triglycerides

  • C10B : Lipid modifying agents, combinations

    • C10BA : Combinations of various lipid modifying agents

      • Atorvastatin + Ezetimibe

      • Ezetimibe + Rosuvastatin

      • Ezetimibe + Simvastatin

      • Fenofibrate + Pravastatin

      • Fenofibrate + Simvastatin

    • C10BX : Lipid modifying agents in combination with other drugs

      • Amlodipine + Atorvastatin

      • Amlodipine + Atorvastatin + Perindopril Arginine

      • Aspirin + Atorvastatin + Ramipril

D : Dermatologicals

• D01: Antifungals for dermatological use

  • D01A : Antifungals for topical use

    • D01AA : Antibiotics

    • D01AC : Imidazole and triazole derivatives

      • Beclomethasone + Clotrimazole

      • Bifonazole

      • Clotrimazole

      • Clotrimazole + Hydrocortisone

      • Diflucortolone + Isoconazole

      • Econazole + Triamcinolone

      • Hydrocortisone + Miconazole

      • Isoconazole

      • Ketoconazole

      • Luliconazole

      • Miconazole

      • Sertaconazole

    • D01AE : Other antifungals for topical use

      • Amorolfine

      • Boric Acid + Resorcinol + Phenol

      • Camphor + Denatured Alcohol + Salicylic Acid

      • Glycyrrhetinic Acid + Undecylenic Acid + Zinc Undecylenate

      • Methyl Salicylate + Salicylic Acid

      • Resorcinol + Salicylic Acid

      • Salicylic Acid

      • Selenium

      • Terbinafine

      • Tolnaftate

  • D01B : Antifungals for systemic use

    • D01BA : Antifungals for systemic use

      • Griseofulvin

      • Terbinafine

• D02: Emollients and protectives

  • D02A : Emollients and protectives

    • D02AA : Silicone products

    • D02AB : Zinc products

    • D02AC : Soft paraffin and fat products

      • Benzalkonium + Liquid Paraffin + Triclosan

    • D02AD : Liquid plasters

    • D02AE : Carbamide products

      • Urea

    • D02AF : Salicylic acid preparations

      • Benzoic Acid + Salicylic Acid

      • Benzoic Acid + Salicylic Acid + Sulphur + Titanium Dioxide

      • Benzoic Acid + Sulphur + Salicylic Acid

    • D02AX : Other emollients and protectives

  • D02B : Protectives against UV-radiation

    • D02BA : Protectives against UV-radiation for topical use

    • D02BB : Protectives against UV-radiation for systemic use

• D03: Preparations for treatment of wounds and ulcers

  • D03A : Cicatrizants

    • D03AA : Cod-liver oil ointments

    • D03AX : Other cicatrizants

      • Centella Asiatica Herba + Plectranthus Amboinicus Extract

  • D03B : Enzymes

    • D03BA : Proteolytic enzymes

• D04: Antipruritics, incl. antihistamines, anesthetics, etc.

  • D04A : Antipruritics, incl. antihistamines, anesthetics, etc.

    • D04AA : Antihistamines for topical use

    • D04AB : Anesthetics for topical use

      • Benzocaine

      • Cetrimide + Chlorhexidine + Lidocaine

      • Cetrimide + Lidocaine

      • Lidocaine

    • D04AX : Other antipruritics

• D05: Antipsoriatics

  • D05A : Antipsoriatics for topical use

    • D05AA : Tars

      • Coal Tar

      • Coal Tar + Phenol + Precipitated Sulphur

      • Coal Tar + Salicylic Acid

      • Coal Tar + Salicylic Acid + Tars

      • Cocois Compound

      • Pine Tar

    • D05AC : Antracen derivatives

    • D05AD : Psoralens for topical use

    • D05AX : Other antipsoriatics for topical use

      • Calcipotriol

      • Calcipotriol + Betamethasone

      • Calcitriol

      • Ichthammol

  • D05B : Antipsoriatics for systemic use

    • D05BA : Psoralens for systemic use

    • D05BB : Retinoids for treatment of psoriasis

      • Acitretin

    • D05BX : Other antipsoriatics for systemic use

• D06: Antibiotics and chemotherapeutics for dermatological use

  • D06A : Antibiotics for topical use

    • D06AA : Tetracycline and derivatives

      • Tetracycline

    • D06AX : Other antibiotics for topical use

      • Bacitracin + Neomycin

      • Bacitracin + Neomycin + Polymyxin B

      • Fusidic Acid

      • Gentamicin

      • Mupirocin

  • D06B : Chemotherapeutics for topical use

    • D06BA : Sulfonamides

      • Silver Sulphadiazine + Chlorhexidine

    • D06BB : Antivirals

      • Acyclovir

      • Imiquimod

    • D06BX : Other chemotherapeutics

      • Metronidazole

  • D06C : Antibiotics and chemotherapeutics, combinations

• D07: Corticosteroids, dermatological preparations

  • D07A : Corticosteroids, plain

    • D07AA : Corticosteroids, weak (group I)

      • Hydrocortisone

    • D07AB : Corticosteroids, moderately potent (group II)

      • Desonide

    • D07AC : Corticosteroids, potent (group III)

      • Betamethasone Dipropionate

      • Betamethasone Valerate

      • Fluocinolone

      • Fluticasone Propionate

      • Hydrocortisone

      • Mometasone

    • D07AD : Corticosteroids, very potent (group IV)

      • Clobetasol

  • D07B : Corticosteroids, combinations with antiseptics

    • D07BA : Corticosteroids, weak, combinations with antiseptics

      • Hydrocortisone + Clioquinol

    • D07BB : Corticosteroids, moderately potent, combinations with antiseptics

    • D07BC : Corticosteroids, potent, combinations with antiseptics

      • Betamethasone Valerate + Clioquinol

    • D07BD : Corticosteroids, very potent, combinations with antiseptics

  • D07C : Corticosteroids, combinations with antibiotics

    • D07CA : Corticosteroids, weak, combinations with antibiotics

      • Fusidic Acid + Hydrocortisone

      • Hydrocortisone + Neomycin

    • D07CB : Corticosteroids, moderately potent, combinations with antibiotics

    • D07CC : Corticosteroids, potent, combinations with antibiotics

      • Betamethasone Dipropionate + Clotrimazole + Gentamicin

      • Betamethasone Dipropionate + Fusidic Acid

      • Betamethasone Dipropionate + Gentamicin

      • Betamethasone Valerate + Fusidic Acid

      • Betamethasone Valerate + Gentamicin

      • Betamethasone Valerate + Gentamicin + Miconazole

      • Betamethasone Valerate + Neomycin

    • D07CD : Corticosteroids, very potent, combinations with antibiotics

  • D07X : Corticosteroids, other combinations

    • D07XA : Corticosteroids, weak, other combinations

      • Hydrocortisone + Urea

    • D07XB : Corticosteroids, moderately potent, other combinations

    • D07XC : Corticosteroids, potent, other combinations

      • Betamethasone Dipropionate + Salicylic Acid

      • Betamethasone Valerate + Salicylic Acid

    • D07XD : Corticosteroids, very potent, other combinations

• D08: Antiseptics and disinfectants

  • D08A : Antiseptics and disinfectants

    • D08AA : Acridine derivatives

    • D08AB : Aluminium agents

    • D08AC : Biguanides and amidines

    • D08AD : Boric acid products

    • D08AE : Phenol and derivatives

    • D08AF : Nitrofuran derivatives

    • D08AG : Iodine products

      • Povidone Iodine

    • D08AH : Quinoline derivatives

    • D08AJ : Quaternary ammonium compounds

    • D08AK : Mercurial products

    • D08AL : Silver products

    • D08AX : Other antiseptics and disinfectants

• D09: Medicated dressings

  • D09A : Medicated dressings

    • D09AA : Medicated dressings with antiinfectives

    • D09AB : Zinc bandages

    • D09AX : Soft paraffin dressings

• D10: Anti-acne preparations

  • D10A : Anti-acne preparations for topical use

    • D10AA : Corticosteroids, combinations for treatment of acne

    • D10AB : Preparations containing sulfur

    • D10AD : Retinoids for topical use in acne

      • Adapalene

      • Adapalene + Benzoyl Peroxide

      • Tretinoin

      • Trifarotene

    • D10AE : Peroxides

      • Adapalene + Benzoyl Peroxide

    • D10AF : Antiinfectives for treatment of acne

      • Benzoyl Peroxide + Clindamycin

      • Clindamycin

      • Erythromycin

    • D10AX : Other anti-acne preparations for topical use

      • Azelaic Acid

      • Clascoterone

  • D10B : Anti-acne preparations for systemic use

    • D10BA : Retinoids for treatment of acne

      • Isotretinoin

    • D10BX : Other anti-acne preparations for systemic use

• D11: Other dermatological preparations

  • D11A : Other dermatological preparations

    • D11AA : Antihidrotics

    • D11AC : Medicated shampoos

    • D11AE : Androgens for topical use

    • D11AF : Wart and anti-corn preparations

      • Fluorouracil + Salicylic Acid

      • Salicylic Acid + Lactic Acid

    • D11AH : Agents for dermatitis, excluding corticosteroids

      • Abrocitinib

      • Crisaborole

      • Dupilumab [Dupixent]

      • Lebrikizumab [Ebglyss]

      • Nemolizumab [Nemluvio]

      • Pimecrolimus

      • Tacrolimus

    • D11AX : Other dermatologicals

      • Brimonidine

      • Calcium Gluconate

      • Finasteride

      • Fluocinolone + Hydroquinone + Tretinoin

      • Ivermectin

      • Minoxidil

G : Genito urinary system and sex hormones

• G01: Gynecological antiinfectives and antiseptics

  • G01A : Antiinfectives and antiseptics, excl. combinations with corticosteroids

    • G01AA : Antibiotics

      • Metronidazole + Nystatin

      • Nystatin

    • G01AB : Arsenic compounds

    • G01AC : Quinoline derivatives

    • G01AD : Organic acids

    • G01AE : Sulfonamides

    • G01AF : Imidazole derivatives

      • Clotrimazole

      • Isoconazole

      • Metronidazole + Miconazole

      • Sertaconazole

    • G01AG : Triazole derivatives

    • G01AX : Other antiinfectives and antiseptics

      • Povidone Iodine

  • G01B : Antiinfectives/antiseptics in combination with corticosteroids

    • G01BA : Antibiotics and corticosteroids

    • G01BC : Quinoline derivatives and corticosteroids

    • G01BD : Antiseptics and corticosteroids

    • G01BE : Sulfonamides and corticosteroids

    • G01BF : Imidazole derivatives and corticosteroids

• G02: Other gynecologicals

  • G02A : Uterotonics

    • G02AB : Ergot alkaloids

    • G02AC : Ergot alkaloids and oxytocin incl. analogues, in combination

      • Oxytocin + Ergometrine

    • G02AD : Prostaglandins

      • Carboprost

      • Dinoprostone

      • Gemeprost

    • G02AX : Other uterotonics

  • G02B : Contraceptives for topical use

    • G02BA : Intrauterine contraceptives

    • G02BB : Intravaginal contraceptives

  • G02C : Other gynecologicals

    • G02CA : Sympathomimetics, labour repressants

    • G02CB : Prolactine inhibitors

      • Bromocriptine

      • Cabergoline

    • G02CC : Antiinflammatory products for vaginal administration

    • G02CX : Other gynecologicals

      • Fezolinetant

• G03: Sex hormones and modulators of the genital system

  • G03A : Hormonal contraceptives for systemic use

    • G03AA : Progestogens and estrogens, fixed combinations

      • Chlormadinone + Ethinylestradiol

      • Desogestrel + Ethinylestradiol

      • Drospirenone + Ethinylestradiol

      • Estradiol + Norgestrel

      • Ethinylestradiol + Norelgestromin

      • Levonorgestrel + Ethinylestradiol

    • G03AB : Progestogens and estrogens, sequential preparations

    • G03AC : Progestogens

      • Drospirenone

      • Etonogestrel

      • Levonorgestrel

      • Medroxyprogesterone Acetate

    • G03AD : Emergency contraceptives

      • Levonorgestrel

      • Ulipristal

  • G03B : Androgens

    • G03BA : 3-oxoandrosten (4) derivatives

      • Testosterone

      • Testosterone Cipionate

      • Testosterone Decanoate + Testosterone Isocaproate + Testosterone Phenylpropionate + Testosterone Propionate

      • Testosterone Undecanoate

    • G03BB : 5-androstanon (3) derivatives

      • Mesterolone

  • G03C : Estrogens

    • G03CA : Natural and semisynthetic estrogens, plain

      • Conjugated Oestrogens

      • Estradiol

    • G03CB : Synthetic estrogens, plain

    • G03CC : Estrogens, combinations with other drugs

    • G03CX : Other estrogens

      • Tibolone

  • G03D : Progestogens

    • G03DA : Pregnen (4) derivatives

      • Hydroxyprogesterone Caproate

      • Medroxyprogesterone Acetate

      • Progesterone

    • G03DB : Pregnadien derivatives

      • Dienogest

      • Dydrogesterone

    • G03DC : Estren derivatives

      • Norethisterone

  • G03E : Androgens and female sex hormones in combination

    • G03EA : Androgens and estrogens

    • G03EB : Androgen, progestogen and estrogen in combination

    • G03EK : Androgens and female sex hormones in combination with other drugs

  • G03F : Progestogens and estrogens in combination

    • G03FA : Progestogens and estrogens, fixed combinations

      • Dydrogesterone + Estradiol

      • Estradiol + Norethisterone

    • G03FB : Progestogens and estrogens, sequential preparations

      • Dydrogesterone + Estradiol

      • Estradiol + Norethisterone

  • G03G : Gonadotropins and other ovulation stimulants

    • G03GA : Gonadotropins

      • Choriogonadotropin Alfa [Ovidrel]

      • Corifollitropin Alfa [Elonva]

      • Follitropin Alfa [Gonal-F]

      • Follitropin Alfa + Lutropin Alfa [Pergoveris]

      • Follitropin Beta [Puregon]

      • Follitropin Delta [Rekovelle]

      • Human Menopausal Gonadotrophin [Menopur]

      • Lutropin Alfa [Luveris]

    • G03GB : Ovulation stimulants, synthetic

      • Clomiphene

  • G03H : Antiandrogens

    • G03HA : Antiandrogens, plain

      • Cyproterone

    • G03HB : Antiandrogens and estrogens

      • Cyproterone + Ethinylestradiol

  • G03X : Other sex hormones and modulators of the genital system

    • G03XA : Antigonadotropins and similar agents

      • Danazol

    • G03XB : Progesterone receptor modulators

      • Mifepristone

    • G03XC : Selective estrogen receptor modulators

      • Raloxifene

    • G03XX : Other sex hormones and modulators of the genital system

• G04: Urologicals

  • G04B : Urologicals

    • G04BA : Acidifiers

    • G04BC : Urinary concrement solvents

    • G04BD : Drugs for urinary frequency and incontinence

      • Flavoxate

      • Mirabegron

      • Oxybutynin

      • Solifenacin

      • Tolterodine

      • Trospium

    • G04BE : Drugs used in erectile dysfunction

      • Alprostadil

      • Avanafil

      • Sildenafil

      • Tadalafil

    • G04BX : Other urologicals

      • Citric Acid + Sodium Bicarbonate + Sodium Citrate + Tartaric Acid

      • Dapoxetine

  • G04C : Drugs used in benign prostatic hypertrophy

    • G04CA : Alpha-adrenoreceptor antagonists

      • Alfuzosin

      • Dutasteride + Tamsulosin

      • Tamsulosin

      • Terazosin

    • G04CB : Testosterone-5-alpha reductase inhibitors

      • Dutasteride

      • Finasteride

    • G04CX : Other drugs used in benign prostatic hypertrophy

H : Systemic hormonal preparations, excl. sex hormones and insulins

• H01: Pituitary and hypothalamic hormones and analogues

  • H01A : Anterior pituitary lobe hormones and analogues

    • H01AA : ACTH

    • H01AB : Thyrotropin

      • Thyrotropin Alfa [Thyrogen]

    • H01AC : Somatropin and somatropin agonists

      • Somapacitan [Sogroya]

      • Somatrogon [Ngenla]

      • Somatropin [Genotropin]

      • Somatropin [Norditropin]

      • Somatropin [Saizen]

      • Somatropin [SciTropin A]

    • H01AX : Other anterior pituitary lobe hormones and analogues

  • H01B : Posterior pituitary lobe hormones

    • H01BA : Vasopressin and analogues

      • Desmopressin

      • Terlipressin

      • Vasopressin

    • H01BB : Oxytocin and analogues

      • Carbetocin

      • Oxytocin

  • H01C : Hypothalamic hormones

    • H01CA : Gonadotropin-releasing hormones

    • H01CB : Somatostatin and analogues

      • Lanreotide

      • Octreotide

      • Pasireotide

      • Somatostatin

    • H01CC : Anti-gonadotropin-releasing hormones

      • Cetrorelix

      • Ganirelix

• H02: Corticosteroids for systemic use

  • H02A : Corticosteroids for systemic use, plain

    • H02AA : Mineralocorticoids

      • Fludrocortisone

    • H02AB : Glucocorticoids

      • Betamethasone

      • Betamethasone Dipropionate + Betamethasone

      • Dexamethasone

      • Hydrocortisone

      • Methylprednisolone

      • Prednisolone

      • Prednisone

      • Triamcinolone

  • H02B : Corticosteroids for systemic use, combination

    • H02BX : Corticosteroids for systemic use, combinations

  • H02C : Antiadrenal preparations

    • H02CA : Anticorticosteroids

• H03: Thyroid therapy

  • H03A : Thyroid preparations

    • H03AA : Thyroid hormones

      • Levothyroxine

  • H03B : Antithyroid preparations

    • H03BA : Thiouracils

      • Propylthiouracil

    • H03BB : Sulfur-containing imidazole derivatives

      • Carbimazole

      • Thiamazole

    • H03BC : Perchlorates

    • H03BX : Other antithyroid preparations

  • H03C : Iodine therapy

    • H03CA : Iodine therapy

• H04: Pancreatic hormones

  • H04A : Glycogenolytic hormones

    • H04AA : Glycogenolytic hormones

      • Glucagon

• H05: Calcium homeostasis

  • H05A : Parathyroid hormones and analogues

    • H05AA : Parathyroid hormones and analogues

      • Teriparatide [Forteo]

      • Teriparatide [MEGAPTH-G]

      • Teriparatide [Sondelbay]

      • Teriparatide [Teriparatide-Teva]

  • H05B : Anti-parathyroid agents

    • H05BA : Calcitonin preparations

      • Calcitonin (Salmon Synthetic)

    • H05BX : Other anti-parathyroid agents

      • Cinacalcet

      • Etelcalcetide

J : Antiinfectives for systemic use

• J01: Antibacterials for systemic use

  • J01A : Tetracyclines

    • J01AA : Tetracyclines

      • Doxycycline

      • Eravacycline

      • Minocycline

      • Tetracycline

      • Tigecycline

  • J01B : Amphenicols

    • J01BA : Amphenicols

  • J01C : Beta-lactam antibacterials, penicillins

    • J01CA : Penicillins with extended spectrum

      • Amoxicillin

      • Ampicillin

    • J01CE : Beta-lactamase sensitive penicillins

      • Benzylpenicillin

      • Phenoxymethylpenicillin

    • J01CF : Beta-lactamase resistant penicillins

      • Cloxacillin

    • J01CG : Beta-lactamase inhibitors

    • J01CR : Combinations of penicillins, incl. beta-lactamase inhibitors

      • Amoxicillin + Clavulanic Acid

      • Ampicillin + Sulbactam

      • Piperacillin + Tazobactam

      • Sultamicillin

  • J01D : Other beta-lactam antibacterials

    • J01DB : First-generation cephalosporins

      • Cefadroxil

      • Cefalexin

      • Cefazolin

    • J01DC : Second-generation cephalosporins

      • Cefaclor

      • Cefuroxime

    • J01DD : Third-generation cephalosporins

      • Avibactam + Ceftazidime

      • Cefotaxime

      • Ceftazidime

      • Ceftriaxone

    • J01DE : Fourth-generation cephalosporins

      • Cefepime

    • J01DF : Monobactams

      • Aztreonam

    • J01DH : Carbapenems

      • Ertapenem

      • Imipenem + Cilastatin

      • Meropenem

      • Meropenem + Vaborbactam

    • J01DI : Other cephalosporins and penems

      • Ceftaroline Fosamil

      • Ceftolozane + Tazobactam

  • J01E : Sulfonamides and trimethoprim

    • J01EA : Trimethoprim and derivatives

    • J01EB : Short-acting sulfonamides

    • J01EC : Intermediate-acting sulfonamides

    • J01ED : Long-acting sulfonamides

    • J01EE : Combinations of sulfonamides and trimethoprim, incl. derivatives

      • Sulfamethoxazole + Trimethoprim

  • J01F : Macrolides, lincosamides and streptogramins

    • J01FA : Macrolides

      • Azithromycin

      • Clarithromycin

      • Erythromycin

      • Erythromycin Ethyl Succinate

      • Roxithromycin

    • J01FF : Lincosamides

      • Clindamycin

      • Lincomycin

    • J01FG : Streptogramins

  • J01G : Aminoglycoside antibacterials

    • J01GA : Streptomycins

      • Streptomycin

    • J01GB : Other aminoglycosides

      • Amikacin

      • Gentamicin

      • Kanamycin

  • J01M : Quinolone antibacterials

    • J01MA : Fluoroquinolones

      • Ciprofloxacin

      • Levofloxacin

      • Lomefloxacin

      • Moxifloxacin

      • Norfloxacin

      • Ofloxacin

    • J01MB : Other quinolones

  • J01R : Combinations of antibacterials

    • J01RA : Combinations of antibacterials

  • J01X : Other antibacterials

    • J01XA : Glycopeptide antibacterials

      • Vancomycin

    • J01XB : Polymyxins

    • J01XC : Steroid antibacterials

    • J01XD : Imidazole derivatives

      • Metronidazole

    • J01XE : Nitrofuran derivatives

      • Nitrofurantoin

    • J01XX : Other antibacterials

      • Daptomycin

      • Fosfomycin

      • Linezolid

      • Tedizolid

• J02: Antimycotics for systemic use

  • J02A : Antimyotics for systemic use

    • J02AA : Antibiotics

      • Amphotericin B

    • J02AB : Imidazole derivatives

      • Ketoconazole

    • J02AC : Triazole and tetrazole derivatives

      • Fluconazole

      • Isavuconazole

      • Itraconazole

      • Posaconazole

      • Voriconazole

    • J02AX : Other antimycotics for systemic use

      • Anidulafungin

      • Caspofungin

      • Micafungin

• J04: Antimycobacterials

  • J04A : Drugs for treatment of tuberculosis

    • J04AA : Aminosalicylic acid and derivatives

    • J04AB : Antibiotics

      • Rifampicin

    • J04AC : Hydrazides

      • Isoniazid

    • J04AD : Thiocarbamide derivatives

    • J04AK : Other drugs for treatment of tuberculosis

      • Ethambutol

      • Pyrazinamide

    • J04AM : Combinations of drugs for treatment of tuberculosis

  • J04B : Drugs for treatment of lepra

    • J04BA : Drugs for treatment of lepra

• J05: Antivirals for systemic use

  • J05A : Direct acting antivirals

    • J05AA : Thiosemicarbazones

    • J05AB : Nucleosides and nucleotides excl. reverse transcriptase inhibitors

      • Acyclovir

      • Ganciclovir

      • Remdesivir

      • Valaciclovir

      • Valganciclovir

    • J05AC : Cyclic amines

    • J05AD : Phosphonic acid derivatives

      • Foscarnet

    • J05AE : Protease inhibitors

      • Atazanavir

      • Darunavir

      • Nirmatrelvir + Ritonavir

      • Ritonavir

    • J05AF : Nucleoside and nucleotide reverse transcriptase inhibitors

      • Abacavir

      • Entecavir

      • Lamivudine

      • Tenofovir Alafenamide

      • Tenofovir Disoproxil Fumarate

      • Zidovudine

    • J05AG : Non-nucleoside reverse transcriptase inhibitors

      • Doravirine

      • Efavirenz

      • Etravirine

      • Rilpivirine

    • J05AH : Neuraminidase inhibitors

      • Oseltamivir

      • Zanamivir

    • J05AJ : Integrase inhibitors

      • Cabotegravir

      • Dolutegravir

      • Raltegravir

    • J05AP : Antivirals for treatment of HCV infections

      • Glecaprevir + Pibrentasvir

      • Ledipasvir + Sofosbuvir

      • Sofosbuvir + Velpatasvir

      • Sofosbuvir + Velpatasvir + Voxilaprevir

    • J05AR : Antivirals for treatment of HIV infections, combinations

      • Abacavir + Dolutegravir + Lamivudine

      • Abacavir + Lamivudine

      • Bictegravir + Emtricitabine + Tenofovir Alafenamide

      • Dolutegravir + Lamivudine

      • Doravirine + Lamivudine + Tenofovir Disoproxil Fumarate

      • Emtricitabine + Rilpivirine + Tenofovir Alafenamide

      • Emtricitabine + Tenofovir Alafenamide

      • Emtricitabine + Tenofovir Disoproxil Fumarate

      • Lamivudine + Zidovudine

      • Lopinavir + Ritonavir

    • J05AX : Other antivirals

      • Baloxavir Marboxil

      • Lenacapavir

      • Letermovir

      • Maraviroc

      • Maribavir

      • Methisoprinol

• J06: Immune sera and immunoglobulins

  • J06A : Immune sera

    • J06AA : Immune sera

      • Botulinum Antitoxin [BAT]

  • J06B : Immunoglobulins

    • J06BA : Immunoglobulins, normal human

      • Immunoglobulins, Normal Human [Flebogamma]

      • Immunoglobulins, Normal Human [Gammagard S/D]

      • Immunoglobulins, Normal Human [Gamunex®-C]

      • Immunoglobulins, Normal Human [Hizentra]

      • Immunoglobulins, Normal Human [HyQvia]

      • Immunoglobulins, Normal Human [Ig Vena]

      • Immunoglobulins, Normal Human [Immunoglobulins SG]

      • Immunoglobulins, Normal Human [Intratect]

      • Immunoglobulins, Normal Human [Kiovig]

      • Immunoglobulins, Normal Human [Octagam]

      • Immunoglobulins, Normal Human [Pentaglobin]

      • Immunoglobulins, Normal Human [Privigen]

    • J06BB : Specific immunoglobulins

      • Anti-D (Rh) Immunoglobulin [HyperRHO]

      • Anti-Rabies Immunoglobulin [HyperRAB]

      • Cytomegalovirus Immunoglobulin [Megalotect CP]

      • Hepatitis B Immunoglobulin [Hepatect CP]

      • Hepatitis B Immunoglobulin [HyperHEP B]

      • Tetanus Immunoglobulin (Human) [HyperTET S/D]

      • Tetanus Immunoglobulin (Human) [Igantet]

    • J06BC : Antibacterial monoclonal antibodies

    • J06BD : Antiviral monoclonal antibodies

      • Nirsevimab [Beyfortus]

      • Palivizumab [Synagis]

• J07: Vaccines

  • J07A : Bacterial vaccines

    • J07AC : Anthrax vaccines

      • Anthrax Antigen Vaccine [Biothrax]

    • J07AD : Brucellosis vaccines

    • J07AE : Cholera vaccines

      • Cholera, Inactivated, Whole Cell Vaccine [Dukoral]

    • J07AF : Diphtheria vaccines

    • J07AG : Hemophilus influenzae B vaccines

      • Haemophilus influenzae type b Vaccine [Hiberix]

    • J07AH : Meningococcal vaccines

      • Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine [Menactra®]

      • Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine [MenQuadfi]

      • Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine [Menveo]

      • Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated Vaccine [Nimenrix]

      • Meningococcus B, Multicomponent Vaccine [Trumenba]

    • J07AJ : Pertussis vaccines

      • Recombinant Acellular Pertussis Vaccine [Pertagen®]

      • Tetanus, Reduced Diphtheria and Acellular Pertussis Vaccine (Tdap) [Adacel®]

      • Tetanus, Reduced Diphtheria and Acellular Pertussis Vaccine (Tdap) [Boostrix]

      • Tetanus, Reduced Diphtheria and Recombinant Acellular Pertussis Vaccine (Tdap) [Boostagen]

    • J07AK : Plague vaccines

    • J07AL : Pneumococcal vaccines

      • Pneumococcal Conjugate Vaccine [10-valent] (PCV10) [Synflorix]

      • Pneumococcal Conjugate Vaccine [13-valent] (PCV13) [Prevenar 13]

      • Pneumococcal Conjugate Vaccine [15-valent] [Vaxneuvance®]

      • Pneumococcal Conjugate Vaccine [20-valent] [Prevenar 20]

      • Pneumococcal Polysaccharide Vaccine [23-valent] (PPSV23) [Pneumovax 23]

    • J07AM : Tetanus vaccines

      • Diphtheria & Tetanus Vaccine [Imovax d.T.]

      • Tetanus Toxoid Vaccine [Tetavax]

    • J07AN : Tuberculosis vaccines

      • Bacillus Calmette-Guérin Vaccine (BCG) [BCG AJV]

    • J07AP : Typhoid vaccines

      • Typhoid, Purified Polysaccharide Antigen Vaccine [Typhim Vi]

    • J07AR : Typhus (exanthematicus) vaccines

    • J07AX : Other bacterial vaccines

  • J07B : Viral vaccines

    • J07BA : Encephalitis vaccines

      • Encephalitis, Japanese, Inactivated, Whole Virus Vaccine [Ixiaro]

      • Encephalitis, Japanese, Live Attenuated Vaccine [Imojev®]

    • J07BB : Influenza vaccines

      • Influenza Quadrivalent Egg-based Vaccine (INF) [Fluarix Tetra]

      • Influenza Quadrivalent Egg-based Vaccine (INF) [Influvac Tetra]

      • Influenza Quadrivalent Egg-based Vaccine (INF) [VaxigripTetra]

      • Influenza Trivalent Vaccine (INF) [Influvac]

      • Influenza Trivalent Vaccine (INF) [Vaxigrip]

      • Influenza, Inactivated, Split Virus or Surface Antigen Vaccine [Aflunov]

      • Influenza, Inactivated, Split Virus or Surface Antigen Vaccine [Panvax®]

    • J07BC : Hepatitis vaccines

      • Hepatitis A & Hepatitis B Vaccine [Twinrix]

      • Hepatitis A, Inactivated, Whole Virus Vaccine [Avaxim]

      • Hepatitis A, Inactivated, Whole Virus Vaccine [Havrix Junior]

      • Hepatitis A, Inactivated, Whole Virus Vaccine [Havrix]

      • Hepatitis B Vaccine (HepB) - Adult [Engerix-B]

      • Hepatitis B Vaccine (HepB) - Child [Engerix-B]

    • J07BD : Measles vaccines

      • Measles, Mumps, Rubella & Varicella Vaccine (MMRV) [Priorix-Tetra]

      • Measles, Mumps, Rubella & Varicella Vaccine (MMRV) [ProQuad]

      • Measles, Mumps, Rubella Vaccine (MMR) [M-M-R II]

      • Measles, Mumps, Rubella Vaccine (MMR) [Priorix]

    • J07BE : Mumps vaccines

    • J07BF : Poliomyelitis vaccines

      • Poliomyelitis, Trivalent, Inactivated, Whole Virus Vaccine [Imovax]

    • J07BG : Rabies vaccines

      • Rabies Virus Vaccine (Inactivated) [Rabipur]

    • J07BH : Rota virus diarrhea vaccines

      • Rotavirus, Live Attenuated Vaccine [Rotarix]

      • Rotavirus, Pentavalent, Live, Reassorted Vaccine [RotaTeq]

    • J07BJ : Rubella vaccines

    • J07BK : Varicella zoster vaccines

      • Varicella Vaccine [Varilrix]

      • Varicella Vaccine [Varivax]

      • Zoster, Purified Antigen Vaccine (Recombinant) [Shingrix]

    • J07BL : Yellow fever vaccines

      • Yellow Fever, Live Attenuated Vaccine [Stamaril]

    • J07BM : Papillomavirus vaccines

      • Human Papillomavirus Vaccine Types 16 and 18 (HPV2) [Cervarix]

      • Papillomavirus (human types 6, 11, 16, 18) Vaccine [Gardasil™]

      • Papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine [Gardasil 9]

    • J07BN : Covid-19 vaccines

      • Covid-19, Protein Subunit Vaccine [Nuvaxovid]

      • Covid-19, RNA-based Vaccine [Comirnaty]

      • Covid-19, RNA-based Vaccine [Spikevax]

    • J07BX : Other viral vaccines

      • Dengue Tetravalent Vaccine [Dengvaxia]

      • Respiratory Syncytial Virus Vaccine [Abrysvo]

      • Respiratory Syncytial Virus Vaccine [Arexvy]

      • Smallpox and Monkeypox Vaccine [Jynneos]

      • Smallpox Vaccine [ACAM2000]

  • J07C : Bacterial and viral vaccines, combined

    • J07CA : Bacterial and viral vaccines, combined

      • Diphtheria, Tetanus, Acellular Pertussis, Poliovirus & Haemophilus influenzae type b Vaccine (DTaP-IPV-Hib) [Infanrix IPV+HiB]

      • Diphtheria, Tetanus, Acellular Pertussis, Poliovirus & Haemophilus influenzae type b Vaccine (DTaP-IPV-Hib) [Pentaxim]

      • Diphtheria, Tetanus, Acellular Pertussis, Poliovirus, Haemophilus influenzae type b & Hepatitis B Vaccine (DTaP-IPV-Hib-HepB) [Hexaxim]

      • Diphtheria, Tetanus, Acellular Pertussis, Poliovirus, Haemophilus influenzae type b & Hepatitis B Vaccine (DTaP-IPV-Hib-HepB) [Infanrix Hexa]

      • Tetanus, Reduced Diphtheria and Acellular Pertussis & Inactivated Poliovirus (Tdap-IPV) Vaccine [Adacel®-Polio]

      • Tetanus, Reduced Diphtheria and Acellular Pertussis & Inactivated Poliovirus (Tdap-IPV) Vaccine [Boostrix Polio]

  • J07X : Other vaccines

    • J07XA : Parasitic vaccines

L : Antineoplastic and immunomodulating agents

• L01: Antineoplastic agents

  • L01A : Alkylating agents

    • L01AA : Nitrogen mustard analogues

      • Bendamustine

      • Chlorambucil

      • Chlormethine

      • Cyclophosphamide

      • Ifosfamide

      • Melphalan

    • L01AB : Alkyl sulfonates

      • Busulfan

      • Treosulfan

    • L01AC : Ethylene imines

      • Thiotepa

    • L01AD : Nitrosoureas

      • Carmustine

    • L01AG : Epoxides

    • L01AX : Other alkylating agents

      • Dacarbazine

      • Temozolomide

  • L01B : Antimetabolites

    • L01BA : Folic acid analogues

      • Methotrexate

      • Pemetrexed

    • L01BB : Purine analogues

      • Clofarabine

      • Fludarabine

      • Mercaptopurine

    • L01BC : Pyrimidine analogues

      • Azacitidine

      • Capecitabine

      • Cytarabine

      • Fluorouracil

      • Gemcitabine

      • Tegafur + Gimeracil + Oteracil

      • Tegafur + Uracil

      • Trifluridine + Tipiracil

  • L01C : Plant alkaloids and other natural products

    • L01CA : Vinca alkaloids and analogues

      • Vinblastine

      • Vincristine

      • Vinorelbine

    • L01CB : Podophyllotoxin derivatives

      • Etoposide

    • L01CC : Colchicine derivatives

    • L01CD : Taxanes

      • Cabazitaxel

      • Docetaxel

      • Paclitaxel

      • Paclitaxel (albumin-bound nanoparticles)

    • L01CE : Topoisomerase 1 (TOP1) inhibitors

      • Irinotecan Hydrochloride Trihydrate

      • Liposomal Irinotecan

    • L01CX : Other plant alkaloids and natural products

      • Trabectedin

  • L01D : Cytotoxic antibiotics and related substances

    • L01DA : Actinomycines

      • Dactinomycin

    • L01DB : Anthracyclines and related substances

      • Daunorubicin

      • Doxorubicin

      • Idarubicin

      • Mitoxantrone

    • L01DC : Other cytotoxic antibiotics

      • Bleomycin

  • L01E : Protein kinase inhibitors

    • L01EA : BCR-ABL tyrosine kinase inhibitors

      • Asciminib

      • Dasatinib

      • Imatinib

      • Nilotinib

      • Ponatinib

    • L01EB : Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

      • Afatinib

      • Dacomitinib

      • Erlotinib

      • Gefitinib

      • Osimertinib

    • L01EC : B-Raf serine-threonine kinase (BRAF) inhibitors

      • Dabrafenib

      • Encorafenib

      • Vemurafenib

    • L01ED : Anaplastic lymphoma kinase (ALK) inhibitors

      • Alectinib

      • Brigatinib

      • Ceritinib

      • Crizotinib

      • Lorlatinib

    • L01EE : Mitogen-activated protein kinase (MEK) inhibitors

      • Binimetinib

      • Cobimetinib

      • Selumetinib

      • Trametinib

    • L01EF : Cyclin-dependent kinase (CDK) inhibitors

      • Abemaciclib

      • Palbociclib

      • Ribociclib

    • L01EG : Mammalian target of rapamycin (mTOR) kinase inhibitors

      • Everolimus

    • L01EH : Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors

      • Lapatinib

      • Neratinib

      • Tucatinib

    • L01EJ : Janus-associated kinase (JAK) inhibitors

      • Fedratinib

      • Momelotinib

      • Ruxolitinib

    • L01EK : Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors

      • Axitinib

      • Fruquintinib

    • L01EL : Bruton's tyrosine kinase (BTK) inhibitors

      • Acalabrutinib

      • Ibrutinib

      • Orelabrutinib

      • Zanubrutinib

    • L01EM : Phosphatidylinositol-3-kinase (Pi3K) inhibitors

      • Alpelisib

    • L01EN : Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors

      • Erdafitinib

      • Pemigatinib

    • L01EX : Other protein kinase inhibitors

      • Cabozantinib

      • Capivasertib

      • Capmatinib

      • Entrectinib

      • Gilteritinib

      • Larotrectinib

      • Lenvatinib

      • Midostaurin

      • Nintedanib

      • Pazopanib

      • Pralsetinib

      • Regorafenib

      • Ripretinib

      • Selpercatinib

      • Sorafenib

      • Sunitinib

      • Tepotinib

  • L01F : Monoclonal antibodies and antibody drug conjugates

    • L01FA : CD20 (Clusters of Differentiation 20) inhibitors

      • Obinutuzumab [Gazyva]

      • Rituximab [MabThera]

      • Rituximab [Rixathon]

      • Rituximab [Truxima®]

    • L01FB : CD22 (Clusters of Differentiation 22) inhibitors

      • Inotuzumab Ozogamicin [Besponsa]

    • L01FC : CD38 (Clusters of Differentiation 38) inhibitors

      • Daratumumab [Darzalex]

      • Isatuximab [Sarclisa]

    • L01FD : HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors

      • Pertuzumab [Perjeta]

      • Trastuzumab [Herceptin]

      • Trastuzumab [Herzuma®]

      • Trastuzumab [Kanjinti]

      • Trastuzumab [Ogivri™]

      • Trastuzumab [Trazher]

      • Trastuzumab [Trazimera]

      • Trastuzumab Deruxtecan [Enhertu]

      • Trastuzumab Emtansine [Kadcyla]

    • L01FE : EGFR (Epidermal Growth Factor Receptor) inhibitors

      • Cetuximab [Erbitux]

      • Panitumumab [Vectibix]

    • L01FF : PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors

      • Atezolizumab [Tecentriq]

      • Avelumab [Bavencio]

      • Dostarlimab [Jemperli]

      • Durvalumab [Imfinzi]

      • Nivolumab [Opdivo]

      • Pembrolizumab [Keytruda]

      • Pembrolizumab [Pembrolizumab]

      • Serplulimab [Zerpidio]

      • Tislelizumab [Tevimbra]

      • Toripalimab [Loqtorzi]

    • L01FG : VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors

      • Bevacizumab [Abevmy™]

      • Bevacizumab [Avamab]

      • Bevacizumab [Avastin]

      • Bevacizumab [Mvasi]

      • Bevacizumab [Vegzelma]

      • Bevacizumab [Zirabev]

      • Ramucirumab [Cyramza]

    • L01FX : Other monoclonal antibodies and antibody drug conjugates

      • Amivantamab [Rybrevant]

      • Blinatumomab [Blincyto]

      • Brentuximab Vedotin [Adcetris®]

      • Datopotamab Deruxtecan [Datroway]

      • Elranatamab [Elrexfio]

      • Enfortumab Vedotin [Padcev®]

      • Epcoritamab [Epkinly]

      • Gemtuzumab Ozogamicin [Mylotarg]

      • Glofitamab [Columvi]

      • Ipilimumab [Yervoy]

      • Loncastuximab Tesirine [Zynlonta®]

      • Mogamulizumab [Poteligeo]

      • Mosunetuzumab [Lunsumio]

      • Polatuzumab Vedotin [Polivy]

      • Sacituzumab Govitecan [Trodelvy]

      • Talquetamab [Talvey]

      • Teclistamab [Tecvayli]

      • Tremelimumab [Imjudo]

      • Zolbetuximab [Vyloy™]

    • L01FY : Combinations of monoclonal antibodies and antibody drug conjugates

      • Nivolumab + Relatlimab [Opdualag]

      • Pertuzumab + Trastuzumab [Phesgo]

  • L01X : Other antineoplastic agents

    • L01XA : Platinum compounds

      • Carboplatin

      • Cisplatin

      • Oxaliplatin

    • L01XB : Methylhydrazines

    • L01XD : Sensitizers used in photodynamic/radiation therapy

      • Aminolevulinic Acid

      • Methyl Aminolevulinate

    • L01XF : Retinoids for cancer treatment

      • Tretinoin

    • L01XG : Proteasome inhibitors

      • Bortezomib

      • Carfilzomib

      • Ixazomib

    • L01XH : Histone deacetylase (HDAC) inhibitors

    • L01XJ : Hedgehog pathway inhibitors

    • L01XK : Poly (ADP-ribose) polymerase (PARP) inhibitors

      • Abiraterone + Niraparib

      • Niraparib

      • Olaparib

      • Talazoparib

    • L01XL : Antineoplastic cell and gene therapy

    • L01XM : Isocitrate dehydrogenase (IDH) inhibitors

    • L01XU : Other antineoplastic agents (cont.)

    • L01XX : Other antineoplastic agents

      • Aflibercept [Zaltrap]

      • Anagrelide

      • Arsenic Trioxide

      • Belzutifan

      • Eribulin

      • Hydroxyurea

      • Lurbinectedin

      • Pegaspargase [Oncaspar]

      • Selinexor

      • Sotorasib

      • Tagraxofusp [Elzonris]

      • Venetoclax

    • L01XY : Combinations of antineoplastic agents

• L02: Endocrine therapy

  • L02A : Hormones and related agents

    • L02AA : Estrogens

    • L02AB : Progestogens

      • Megestrol

    • L02AE : Gonadotropin releasing hormone analogues

      • Goserelin

      • Leuprorelin Acetate

      • Triptorelin

    • L02AX : Other hormones

  • L02B : Hormone antagonists and related agents

    • L02BA : Anti-estrogens

      • Elacestrant

      • Fulvestrant

      • Tamoxifen

    • L02BB : Anti-androgens

      • Apalutamide

      • Bicalutamide

      • Darolutamide

      • Enzalutamide

    • L02BG : Aromatase inhibitors

      • Anastrozole

      • Exemestane

      • Letrozole

    • L02BX : Other hormone antagonists and related agents

      • Abiraterone

      • Degarelix

• L03: Immunostimulants

  • L03A : Immunostimulants

    • L03AA : Colony stimulating factors

      • Filgrastim [Accofil]

      • Filgrastim [Neupogen]

      • Filgrastim [Nivestim]

      • Filgrastim [Zarzio]

      • Lipegfilgrastim [Lonquex]

      • Pegfilgrastim [Fulphila™]

      • Pegfilgrastim [Neulastim]

      • Pegfilgrastim [Pelgraz]

    • L03AB : Interferons

      • Interferon Beta-1a [Rebif]

      • Peginterferon Alfa-2a [Pegasys]

      • Ropeginterferon Alfa-2b [Besremi]

    • L03AC : Interleukins

    • L03AX : Other immunostimulants

      • Plerixafor

      • Thymosin Alpha 1 [Zadaxin]

• L04: Immunosuppressants

  • L04A : Immunosuppressants

    • L04AA : Selective immunosuppressants

      • Alemtuzumab [Lemtrada]

      • Antilymphocyte Immunoglobulin (Horse) [Atgam]

      • Antithymocyte Immunoglobulin (Rabbit) [Grafalon]

      • Antithymocyte Immunoglobulin (Rabbit) [Thymoglobuline]

      • Apremilast

      • Cladribine

      • Mycophenolate Mofetil

      • Mycophenolate Sodium

    • L04AB : Tumor necrosis factor alpha (TNF-α) inhibitors

      • Adalimumab [Abrilada]

      • Adalimumab [Amgevita]

      • Adalimumab [Hulio]

      • Adalimumab [Humira]

      • Adalimumab [Hyrimoz]

      • Adalimumab [Idacio]

      • Adalimumab [Yuflyma]

      • Etanercept [Enbrel]

      • Etanercept [Nepexto]

      • Golimumab [Simponi]

      • Infliximab [Ixifi]

      • Infliximab [Remicade]

      • Infliximab [Remsima]

    • L04AC : Interleukin inhibitors

      • Basiliximab [Simulect]

      • Guselkumab [Tremfya]

      • Ixekizumab [Taltz]

      • Risankizumab [Skyrizi]

      • Satralizumab [Enspryng]

      • Secukinumab [Cosentyx]

      • Siltuximab [Sylvant]

      • Spesolimab [Spevigo]

      • Tildrakizumab [Ilumya]

      • Tocilizumab [Actemra]

      • Ustekinumab [Stelara]

    • L04AD : Calcineurin inhibitors

      • Ciclosporin

      • Tacrolimus

    • L04AE : Sphingosine-1-phosphate (S1P) receptor modulators

      • Etrasimod

      • Fingolimod

      • Ozanimod

      • Siponimod

    • L04AF : Janus-associated kinase (JAK) inhibitors

      • Baricitinib

      • Deucravacitinib

      • Filgotinib

      • Ritlecitinib

      • Tofacitinib

      • Upadacitinib

    • L04AG : Monoclonal antibodies

      • Belimumab [Benlysta]

      • Natalizumab [Tysabri]

      • Ocrelizumab [Ocrevus]

      • Ofatumumab [Kesimpta]

      • Vedolizumab [Entyvio]

    • L04AH : Mammalian target of rapamycin (mTOR) kinase inhibitors

      • Everolimus

      • Sirolimus

    • L04AJ : Complement inhibitors

      • Avacopan

      • Danicopan

      • Eculizumab [Soliris]

      • Ravulizumab [Ultomiris]

    • L04AK : Dihydroorotate dehydrogenase (DHODH) inhibitors

      • Leflunomide

      • Teriflunomide

    • L04AX : Other immunosuppressants

      • Azathioprine

      • Dimethyl Fumarate

      • Lenalidomide

      • Methotrexate

      • Pirfenidone

      • Pomalidomide

      • Thalidomide

M : Musculo-skeletal system

• M01: Antiinflammatory and antirheumatic products

  • M01A : Antiinflammatory and antirheumatic products, non-steroids

    • M01AA : Butylpyrazolidines

    • M01AB : Acetic acid derivatives and related substances

      • Aceclofenac

      • Diclofenac

      • Indometacin

      • Ketorolac

    • M01AC : Oxicams

      • Meloxicam

      • Piroxicam

    • M01AE : Propionic acid derivatives

      • Dexketoprofen

      • Ibuprofen

      • Ketoprofen

      • Naproxen

    • M01AG : Fenamates

      • Mefenamic Acid

    • M01AH : Coxibs

      • Celecoxib

      • Etoricoxib

      • Parecoxib

    • M01AX : Other antiinflammatory and antirheumatic agents, non-steroids

  • M01B : Antiinflammatory/antirheumatic agents in combination

    • M01BA : Antiinflammatory/antirheumatic agents in combination with corticosteroids

    • M01BX : Other antiinflammatory/antirheumatic agents in combination with other drugs

  • M01C : Specific antirheumatic agents

    • M01CA : Quinolines

    • M01CB : Gold preparations

    • M01CC : Penicillamine and similar agents

      • Penicillamine

    • M01CX : Other specific antirheumatic agents

• M02: Topical products for joints and muscular pain

  • M02A : Topical products for joints and muscular pain

    • M02AA : Antiinflammatory preparations, non-steroids for topical use

      • Diclofenac

      • Flurbiprofen

      • Ketoprofen

      • Piroxicam

    • M02AB : Capsaicin and similar agents

    • M02AC : Preparations with salicylic acid derivatives

    • M02AX : Other topical products for joint and muscular pain

• M03: Muscle relaxants

  • M03A : Muscle relaxants, peripherally acting agents

    • M03AA : Curare alkaloids

    • M03AB : Choline derivatives

      • Suxamethonium

    • M03AC : Other quaternary ammonium compounds

      • Atracurium

      • Cisatracurium

      • Mivacurium

      • Rocuronium

    • M03AX : Other muscle relaxants, peripherally acting agents

      • Botulinum toxin type A complex [Botox]

      • Botulinum toxin type A complex [Dysport]

      • Botulinum toxin type A complex [Nabota]

      • Botulinum toxin type A complex [Xeomin®]

  • M03B : Muscle relaxants, centrally acting agents

    • M03BA : Carbamic acid esters

    • M03BB : Oxazol, thiazine, and triazine derivatives

    • M03BC : Ethers, chemically close to antihistamines

      • Orphenadrine

      • Paracetamol + Orphenadrine

    • M03BX : Other centrally acting agents

      • Baclofen

      • Eperisone

  • M03C : Muscle relaxants, directly acting agents

    • M03CA : Dantrolene and derivatives

• M04: Antigout preparations

  • M04A : Antigout preparations

    • M04AA : Preparations inhibiting uric acid production

      • Allopurinol

      • Febuxostat

    • M04AB : Preparations increasing uric acid excretion

      • Benzbromarone

      • Probenecid

    • M04AC : Preparations with no effect on uric acid metabolism

      • Colchicine

    • M04AX : Other antigout preparations

• M05: Drugs for treatment of bone diseases

  • M05B : Drugs affecting bone structure and mineralization

    • M05BA : Bisphosphonates

      • Alendronic Acid

      • Ibandronic Acid

      • Pamidronic Acid

      • Risedronic Acid

      • Zoledronic Acid

    • M05BB : Bisphosphonates, combinations

      • Alendronic Acid + Vitamin D3

    • M05BC : Bone morphogenetic proteins

    • M05BX : Other drugs affecting bone structure and mineralization

      • Burosumab [Crysvita®]

      • Denosumab [Prolia]

      • Denosumab [Xgeva]

      • Romosozumab [Evenity]

• M09: Other drugs for disorders of the musculo-skeletal system

  • M09A : Other drugs for disorders of the musculo-skeletal system

    • M09AA : Quinine and derivatives

    • M09AB : Enzymes

    • M09AX : Other drugs for disorders of the musculo-skeletal system

      • Hyaluronic Acid

      • Nusinersen

      • Risdiplam

N : Nervous system

• N01: Anesthetics

  • N01A : Anesthetics, general

    • N01AA : Ethers

    • N01AB : Halogenated hydrocarbons

      • Desflurane

      • Isoflurane

      • Sevoflurane

    • N01AF : Barbiturates, plain

    • N01AG : Barbiturates in combination with other drugs

    • N01AH : Opioid anesthetics

      • Alfentanil

      • Fentanyl

      • Remifentanil

    • N01AX : Other general anesthetics

      • Etomidate

      • Ketamine

      • Propofol

  • N01B : Anesthetics, local

    • N01BA : Esters of aminobenzoic acid

    • N01BB : Amides

      • Adrenaline + Mepivacaine

      • Articaine + Adrenaline

      • Bupivacaine

      • Bupivacaine + Adrenaline

      • Cetrimide + Lidocaine

      • Levobupivacaine

      • Lidocaine

      • Lidocaine + Adrenaline

      • Lidocaine + Phenylephrine

      • Lidocaine + Prilocaine

      • Lidocaine + Tetracaine

      • Mepivacaine

      • Prilocaine

      • Ropivacaine

    • N01BC : Esters of benzoic acid

    • N01BX : Other local anesthetics

• N02: Analgesics

  • N02A : Opioids

    • N02AA : Natural opium alkaloids

      • Morphine

      • Naloxone + Oxycodone

      • Oxycodone

    • N02AB : Phenylpiperidine derivatives

      • Fentanyl

      • Pethidine

    • N02AC : Diphenylpropylamine derivatives

    • N02AD : Benzomorphan derivatives

    • N02AE : Oripavine derivatives

    • N02AF : Morphinan derivatives

      • Dinalbuphine Sebacate

    • N02AG : Opioids in combination with antispasmodics

    • N02AJ : Opioids in combination with non-opioid analgesics

      • Dexketoprofen + Tramadol

      • Paracetamol + Tramadol

    • N02AX : Other opioids

      • Tramadol

  • N02B : Other analgesics and antipyretics

    • N02BA : Salicylic acid and derivatives

      • Aspirin

      • Caffeine + Salicylamide

    • N02BB : Pyrazolones

    • N02BE : Anilides

      • Caffeine + Chlorpheniramine + Paracetamol + Phenylephrine

      • Caffeine + Codeine + Paracetamol

      • Caffeine + Guaifenesin + Paracetamol

      • Caffeine + Paracetamol

      • Caffeine + Paracetamol + Phenylephrine

      • Chlorpheniramine + Paracetamol

      • Chlorpheniramine + Paracetamol + Phenylephrine

      • Chlorpheniramine + Paracetamol + Pseudoephedrine

      • Codeine + Paracetamol

      • Dextromethorphan + Paracetamol + Pseudoephedrine

      • Guaifenesin + Paracetamol + Phenylephrine

      • Ibuprofen + Paracetamol

      • Ibuprofen + Paracetamol + Phenylephrine

      • Pamabrom + Paracetamol

      • Paracetamol

      • Paracetamol + Phenylephrine

      • Paracetamol + Phenylephrine + Vitamin C

      • Paracetamol + Pseudoephedrine

    • N02BF : Gabapentinoids

      • Gabapentin

      • Pregabalin

    • N02BG : Other analgesics and antipyretics

      • Methoxyflurane

  • N02C : Antimigraine preparations

    • N02CA : Ergot alkaloids

      • Ergotamine + Caffeine

    • N02CB : Corticosteroid derivatives

    • N02CC : Selective serotonin (5HT1) agonists

      • Eletriptan

      • Naratriptan

      • Sumatriptan

      • Zolmitriptan

    • N02CD : Calcitonin gene-related peptide (CGRP) antagonists

      • Atogepant

      • Eptinezumab [Vyepti]

      • Erenumab [Aimovig]

      • Fremanezumab [Ajovy]

      • Galcanezumab [Emgality]

      • Rimegepant

    • N02CX : Other antimigraine preparations

• N03: Antiepileptics

  • N03A : Antiepileptics

    • N03AA : Barbiturates and derivatives

      • Phenobarbitone

    • N03AB : Hydantoin derivatives

      • Phenytoin

    • N03AC : Oxazolidine derivatives

    • N03AD : Succinimide derivatives

    • N03AE : Benzodiazepine derivatives

      • Clonazepam

    • N03AF : Carboxamide derivatives

      • Carbamazepine

      • Rufinamide

    • N03AG : Fatty acid derivatives

      • Valproate

      • Vigabatrin

    • N03AX : Other antiepileptics

      • Lamotrigine

      • Levetiracetam

      • Perampanel

      • Topiramate

• N04: Anti-parkinson drugs

  • N04A : Anticholinergic agents

    • N04AA : Tertiary amines

      • Benzhexol

    • N04AB : Ethers chemically close to antihistamines

    • N04AC : Ethers of tropine or tropine derivatives

      • Benztropine

  • N04B : Dopaminergic agents

    • N04BA : Dopa and dopa derivatives

      • Levodopa + Benserazide

      • Levodopa + Carbidopa

      • Levodopa + Carbidopa + Entacapone

    • N04BB : Adamantane derivatives

      • Amantadine

    • N04BC : Dopamine agonists

      • Bromocriptine

      • Piribedil

      • Pramipexole

      • Ropinirole

    • N04BD : Monoamine oxidase B inhibitors

      • Rasagiline

      • Safinamide

      • Selegiline

    • N04BX : Other dopaminergic agents

      • Entacapone

  • N04C : Other antiparkinson drugs

    • N04CX : Other antiparkinson drugs

• N05: Psycholeptics

  • N05A : Antipsychotics

    • N05AA : Phenothiazines with aliphatic side-chain

      • Chlorpromazine

    • N05AB : Phenothiazines with piperazine structure

      • Perphenazine

      • Prochlorperazine

      • Trifluoperazine

    • N05AC : Phenothiazines with piperidine structure

    • N05AD : Butyrophenone derivatives

      • Haloperidol

    • N05AE : Indole derivatives

      • Lurasidone

    • N05AF : Thioxanthene derivatives

      • Flupenthixol Decanoate

      • Zuclopenthixol Decanoate

    • N05AG : Diphenylbutylpiperidine derivatives

    • N05AH : Diazepines, oxazepines, thiazepines and oxepines

      • Clozapine

      • Olanzapine

      • Quetiapine

    • N05AL : Benzamides

      • Amisulpride

      • Sulpiride

    • N05AN : Lithium

      • Lithium Carbonate

    • N05AX : Other antipsychotics

      • Aripiprazole

      • Brexpiprazole

      • Cariprazine

      • Paliperidone

      • Paliperidone Palmitate

      • Risperidone

  • N05B : Anxiolytics

    • N05BA : Benzodiazepine derivatives

      • Alprazolam

      • Bromazepam

      • Chlordiazepoxide

      • Clobazam

      • Diazepam

      • Lorazepam

      • Pinazepam

    • N05BB : Diphenylmethane derivatives

      • Hydroxyzine

    • N05BC : Carbamates

    • N05BD : Dibenzo-bicyclo-octadiene derivatives

    • N05BE : Azaspirodecanedione derivatives

    • N05BX : Other anxiolytics

  • N05C : Hypnotics and sedatives

    • N05CA : Barbiturates, plain

    • N05CB : Barbiturates, combinations

    • N05CC : Aldehydes and derivatives

      • Paraldehyde

    • N05CD : Benzodiazepine derivatives

      • Midazolam

    • N05CE : Piperidinedione derivatives

    • N05CF : Benzodiazepine related drugs

      • Zolpidem

      • Zopiclone

    • N05CH : Melatonin receptor agonists

      • Melatonin

    • N05CJ : Orexin receptor antagonists

      • Lemborexant

    • N05CM : Other hypnotics and sedatives

      • Dexmedetomidine

    • N05CX : Hypnotics and sedatives in combination, excl. barbiturates

• N06: Psychoanaleptics

  • N06A : Antidepressants

    • N06AA : Non-selective monoamine reuptake inhibitors

      • Amitriptyline

      • Clomipramine

      • Dothiepin

      • Imipramine

      • Nortriptyline

    • N06AB : Selective serotonin reuptake inhibitors

      • Escitalopram

      • Fluoxetine

      • Fluvoxamine

      • Paroxetine

      • Sertraline

    • N06AF : Monoamine oxidase inhibitors, non-selective

    • N06AG : Monoamine oxidase A inhibitors

      • Moclobemide

    • N06AX : Other antidepressants

      • Agomelatine

      • Bupropion

      • Desvenlafaxine

      • Duloxetine

      • Esketamine

      • Mirtazapine

      • Tianeptine

      • Trazodone

      • Venlafaxine

      • Vortioxetine

  • N06B : Psychostimulants, agents used for ADHD and nootropics

    • N06BA : Centrally acting sympathomimetics

      • Lisdexamfetamine Dimesylate

      • Methylphenidate

    • N06BC : Xanthine derivatives

      • Caffeine

    • N06BX : Other psychostimulants and nootropics

      • Piracetam

      • Vinpocetine

  • N06C : Psycholeptics and psychoanaleptics in combination

    • N06CA : Antidepressants in combination with psycholeptics

      • Flupenthixol + Melitracen

    • N06CB : Psychostimulants in combination with psycholeptics

  • N06D : Anti-dementia drugs

    • N06DA : Anticholinesterases

      • Donepezil

      • Galantamine

      • Rivastigmine

    • N06DX : Other anti-dementia drugs

      • Donanemab [Lormalzi]

      • Lecanemab [Leqembi]

      • Memantine

• N07: Other nervous system drugs

  • N07A : Parasympathomimetics

    • N07AA : Anticholinesterases

      • Distigmine

      • Neostigmine

      • Pyridostigmine

    • N07AB : Choline esters

    • N07AX : Other parasympathomimetics

      • Pilocarpine

  • N07B : Drugs used in addictive disorders

    • N07BA : Drugs used in nicotine dependence

      • Nicotine

      • Varenicline

    • N07BB : Drugs used in alcohol dependence

      • Naltrexone

    • N07BC : Drugs used in opioid dependence

  • N07C : Antivertigo preparations

    • N07CA : Antivertigo preparations

      • Betahistine Dihydrochloride

      • Betahistine Mesilate

      • Cinnarizine

      • Flunarizine

  • N07X : Other nervous system drugs

    • N07XA : Gangliosides and ganglioside derivatives

    • N07XX : Other nervous system drugs

      • Riluzole

      • Tafamidis

      • Valbenazine

      • Vutrisiran